- Home
- / Kindred Biosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Kindred Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$9.3
2021-09-03
Market Capitalization
$419.3 M
2021-09-03
Revenue
$42.2 M
FY, 2020
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | 2.0M | 4.3M | 42.2M | ||||
| Cost of goods sold | 324.0K | 587.0K | 4.6M | ||||
| Gross profit | 1.6M | 3.7M | 37.5M | ||||
| Gross profit margin, % | 83.5% | 86.2% | 89.0% | ||||
| General and administrative expense | 8.5M | 7.9M | 8.3M | 14.0M | 26.5M | 37.9M | 22.0M |
| Operating expense total | 27.2M | 27.3M | 22.8M | 31.7M | 52.9M | 66.2M | 57.5M |
| EBIT | (27.2M) | (27.3M) | (22.8M) | (31.7M) | (51.3M) | (62.6M) | (20.0M) |
| EBIT margin, % | -2607.1% | -1470.1% | -47.4% | ||||
| Investment income | 94.0K | 132.0K | |||||
| Interest income | 325.0K | 774.0K | 1.6M | 1.2M | |||
| Net Income | (27.1M) | (27.1M) | (22.5M) | (30.9M) | (49.7M) | (61.4M) | (21.8M) |